Results 181 to 190 of about 12,985,526 (358)

Malaria elimination practices in China from the perspective of health system and social development. [PDF]

Infect Dis Poverty
Song X, Liu Z, Li N, Chen L, Liu M, Liu J, Zhang Y, Wang M, Ren M.   +8 more
europepmc   +1 more source

1A1-K05 Development of Ankle-Foot Othosis Intelligently controlled by Shear-Type Compact MR Brake and its Control

, 2007
M. Tokuda, Taigo Kakehashi, Sayo Yamaguchi, Takehito Kikuchi, Shouji MORIMOTO, Yasunori Hashimoto, A. Nakagawa, Yasushi AKAZAWA, Junji FURUSHO   +8 more
openalex   +2 more sources

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

201 Development of Minute ER Device of Liquid Crystal with Functions of Flow Rate Sensing and Control(1)

, 2006
Takatsune NARUMI, Naoki SASAKI, Tomiichi HASEGAWA   +2 more
openalex   +2 more sources

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Development of method of choice of the controlled parameters of mobile launcher

, 2009
С. В. Герасимов, A. A. Podorozhnyak, Y. B. Pribylev   +2 more
openalex   +2 more sources

Nuclear receptors: Lipid and hormone sensors with essential roles in the control of cancer development

, 2020
Joan Font-Díaz, Alba Jiménez‐Panizo, Carmé Caelles, María dM Vivanco, Paloma Pérez, Ana Aranda, Eva Estébanez‐Perpiñá, Antonio Castrillo, Mercedes Ricote, Annabel F. Valledor   +9 more
openalex   +2 more sources

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Development of High Growth Rate SiC Epi-Reactor with Controlled Thermal Gradient

, 2007
M. Ito, Hidekazu Tsuchida, Isaho Kamata, L. Storasta   +3 more
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source